Per-Olof Schrewelius Is The Chief Financial Officer of Alligator Bioscience AB (publ) (STO:ATORX) And They Just Spent kr86k On Shares
Whilst it may not be a huge deal, we thought it was good to see that the Alligator Bioscience AB (publ) (STO:ATORX) Chief Financial Officer, Per-Olof Schrewelius, recently bought kr86k worth of stock, for kr8.60 per share. While we're hesitant to get too excited about a purchase of that size, we do note it increased their holding by a solid 20%.
View our latest analysis for Alligator Bioscience
Alligator Bioscience Insider Transactions Over The Last Year
In the last twelve months, the biggest single purchase by an insider was when Independent Director Jonas Sjögren bought kr1.1m worth of shares at a price of kr11.10 per share. That means that an insider was happy to buy shares at above the current price of kr8.35. Their view may have changed since then, but at least it shows they felt optimistic at the time. In our view, the price an insider pays for shares is very important. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.
Alligator Bioscience insiders may have bought shares in the last year, but they didn't sell any. You can see the insider transactions (by individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
Alligator Bioscience is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.
Insider Ownership of Alligator Bioscience
Many investors like to check how much of a company is owned by insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Insiders own 20% of Alligator Bioscience shares, worth about kr122m. We've certainly seen higher levels of insider ownership elsewhere, but these holdings are enough to suggest alignment between insiders and the other shareholders.
So What Do The Alligator Bioscience Insider Transactions Indicate?
It is good to see the recent insider purchase. And the longer term insider transactions also give us confidence. However, we note that the company didn't make a profit over the last twelve months, which makes us cautious. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Alligator Bioscience. That's what I like to see! Of course, the future is what matters most. So if you are interested in Alligator Bioscience, you should check out this free report on analyst forecasts for the company.
If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.
